Cancer Drug May Be Lifesaver for Hospitalized COVID Patients

WEDNESDAY, July 6, 2022 (HealthDay News)

An experimental drug used to fight cancer may reduce the risk of death for COVID-19 patients by roughly 55%, a new study suggests.

The drug, sabizabulin, has been found effective in aiding severely ill COVID-19 patients, more so than previously authorized drugs, researchers report July 6 in the